Harding, James J.
Bauer, Todd M.
Tan, Daniel S. W.
Bedard, Philippe L.
Rodon, Jordi
Doi, Toshihiko
Schnell, Christian
Iyer, Varsha
Baffert, Fabienne
Radhakrishnan, Rajkumar
Fabre, Claire
Juric, Dejan
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 30 April 2018
Accepted: 21 June 2018
First Online: 3 August 2018
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: James J. Harding and Todd M. Bauer have nothing to disclose. Daniel SW Tan reports grants and personal fees from Novartis, Boehringer Ingelheim, Pfizer, GlaxoSmithKline, Astra Zeneca and Merck, outside the submitted work. Philippe L. Bedard reports grants from Novartis, during the conduct of the study. Jordi Rodon reports grants from Novartis, during the conduct of the study and personal fees from Novartis, outside the submitted work. Toshihiko Doi reports grants and personal fees from Lilly, Chugai Pharma, Kyowa Hakko Kirin, MSD, Daiichi Sankyo, Taiho and Sumitomo Group, and personal fees from Amgen, and grants from Novartis, Merck Serono, Astellas Pharma, Janssen, Boehringer Ingelheim, Takeda, Pfizer, Celgene, Bristol Myers Squibb, Abbvie and Quintiles, outside the submitted work. Christian Schnell is a Novartis employee. Varsha Iyer has nothing to disclose. Fabienne Baffert, Rajkumar Radhakrishnan and Claire Fabre are Novartis employees. Dejan Juric reports personal fees from Novartis, Genentech, EMD Serono, and Eisai, outside the submitted work.